Patient-reported barriers to osteoporosis therapy.

about

Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study.Factors related to intentional non-initiation of bisphosphonate treatment in patients with a high fracture risk in primary care: a qualitative study

P2860

Q45339887-5FC44505-48A5-4947-BD31-643B3069FFB2 Q58713667-8EDDEEF7-3D7E-4878-9577-BAD1D4F46BFC

P2860

Patient-reported barriers to osteoporosis therapy.

Item

http://www.wikidata.org/entity/Q36853473

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient-reported barriers to osteoporosis therapy.

@en

type

Item

label

Patient-reported barriers to osteoporosis therapy.

@en

prefLabel

Patient-reported barriers to osteoporosis therapy.

@en

P1476

Patient-reported barriers to osteoporosis therapy.

@en

P2093

Brianna R Lindsay

http://www.w3.org/2001/XMLSchema#string

Jane Babrowicz

http://www.w3.org/2001/XMLSchema#string

Jennifer Bauer

http://www.w3.org/2001/XMLSchema#string

Rebecca Hahn

http://www.w3.org/2001/XMLSchema#string

Temitope Olufade

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis

Estimating prevalence of osteoporosis: examples from industrialized countries.

Reasons for not initiating osteoporosis therapy among a managed care population.

Safety considerations with bisphosphonates for the treatment of osteoporosis.

Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.

Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women.

Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties.

P2888

s11657-016-0272-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11657-016-0272-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27129487

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

4851700

http://www.w3.org/2001/XMLSchema#string

Patient-reported barriers to osteoporosis therapy.

about

P2860

P2860

Patient-reported barriers to osteoporosis therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P921

P932